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We studied the synthesis of surfactant and the effect of prenatal betamethasone treatment 
 
in vivo
 
 in
very preterm baboons. Ten pregnant baboons were randomized to receive either betamethasone
(beta) or saline (control) 48 and 24 h before preterm delivery. The newborn baboons were intu-
bated, treated with surfactant, and ventilated for 6 d. They received a 24-h infusion with the stable
isotope [U-
 
13
 
C]glucose as precursor for the synthesis of palmitic acid in surfactant phosphatidylcho-
line (PC). Palmitic acid in surfactant PC became enriched 27 
 
6
 
 2 h after the start of the isotope infu-
sion and was maximally enriched at 100 
 
6
 
 4 h. The fractional synthesis rate of PC palmitate in the
beta group (1.5 
 
6
 
 0.2%/d) was increased by 129% above control (0.7 
 
6
 
 0.1%/d) (p 
 
,
 
 0.02, Mann–
Whitney U test). The absolute synthesis rate of PC in the beta group [1.6 
 
6
 
 0.3 
 
m
 
mol/kg/d] was in-
creased by 128% above controls [0.7 
 
6
 
 0.2 
 
m
 
mol/kg/d] (p 
 
,
 
 0.02). These data show that the synthe-
sis of endogenous surfactant from plasma glucose as precursor is a slow process. It is shown, for the
first time 
 
in vivo
 
, that prenatal glucocorticosteroids stimulate the synthesis of surfactant PC in the
very premature baboon. 
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Little is known about surfactant metabolism after preterm de-
livery of humans or animals. In term and preterm monkeys
and lambs with surfactant deficiency, the pool sizes of surfac-
tant in the alveolus increase slowly postnatally (1, 2). Recov-
ery from respiratory distress syndrome (RDS) in monkeys is
associated with larger increases in lung pool sizes of disatu-
rated phosphatidylcholine (DSPC) than is nonrecovery from
RDS (3). In the preterm human, the accumulation of alveolar
surfactant is slow, as shown by a slow postnatal increase in sur-
factant phosphatidylcholine (PC) concentration in tracheal as-
pirates (4), and low synthesis rates of surfactant PC (5).
The improved pulmonary function of previously unstressed
preterm animals after treatment with prenatal glucocorticoids
results primarily from structural changes of the lungs that in-
clude increased lung gas volume, decreased perilobular con-
nective tissue, decreased alveolar wall thickness (6), and induc-
tion of antioxidant enzyme activities (7). Improved pulmonary
function also can result from increased amounts of surfactant.
 
In vitro
 
, glucocorticoids increase the activity of a number of
enzymes of the surfactant synthetic pathway and increase sur-
factant phospholipid and protein synthesis, and lamellar body
appearance in human fetal lung explants (8–10). However, in
most 
 
in vivo
 
 studies with preterm rabbits, preterm lambs, and
very preterm baboons, treatment with betamethasone 48 h be-
fore delivery does not increase surfactant pool sizes of the al-
veolar lavage and total lung (2, 11, 12). We reported large in-
creases in surfactant PC pools after birth in both the lung
tissue and alveolar pools of preterm ventilated baboons dur-
ing the first days of life, and pool sizes were not significantly
increased by prenatal glucocorticoids (2). As pool size de-
pends on both synthesis and clearance of surfactant, the mea-
surement of the pool size is not equivalent to the measure-
ment of the production rate. Therefore, it is currently unclear
whether prenatal glucocorticoids increase surfactant produc-
tion after preterm delivery.
We studied postnatal endogenous surfactant metabolism in
the very premature baboon and tested the hypothesis that pre-
natal corticosteroids influence the synthesis of endogenous
surfactant 
 
in vivo
 
. These studies are comparable to our report
of endogenous surfactant metabolism in preterm human in-
fants (5) because we used the same stable nonradioactive iso-
tope, [U-
 
13
 
C]glucose, as a precursor for the synthesis of pal-
mitic acid in surfactant PC.
 
(
 
Received in original form August 19, 1998 and in revised form March 30, 1999
 
)
Supported by the Sophia Foundation for Medical Research (SSWO 184) and by
the National Institute of Child Health (HL 52635) (The Southwest Foundation for
Biomedical Research BPD Resource Center).
Correspondence and requests for reprints should be addressed to Luc J. I. Zim-
mermann, M.D., Ph.D., Neonatology, Sophia Children’s Hospital, Dr. Molewa-
terplein 60, 3015 GJ Rotterdam, The Netherlands. E-mail: Zimmermann@alkg.azr.nl
 1482
 
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE VOL 160 1999
 
METHODS
 
Animal Treatment and Postnatal Care
 
Animal care, fetal treatments, deliveries, and the postnatal studies
were performed at the Southwest Foundation for Biomedical Re-
search (San Antonio, TX) as reported previously (2). All procedures
were reviewed and conformed with AAALAC guidelines. Pregnan-
cies were dated on the basis of cycle dates and growth parameters de-
termined by prenatal ultrasounds performed at estimated fetal gesta-
tional ages of 70 and 100 d. At 123 
 
6
 
 2 d of gestation (term is 185 d)
the pregnant baboons were randomly assigned to receive 6 mg of be-
tamethasone (Celestone Soluspan; Schering Pharmaceuticals, Kenil-
worth, NJ) or saline by intramuscular injection 48 and 24 h before de-
livery. At delivery, the pregnant baboons were sedated with ketamine
(10 mg/kg, intramuscular), intubated, and anesthetized with 1.5% hal-
othane. The preterm fetuses were delivered by cesarean section at
125 
 
6
 
 2 d gestation and intubated. The newborns received sufactant
(100 mg/kg) by tracheal instillation (Survanta; donated by Ross Pro-
ducts, Columbus, OH). At birth, animals received parenteral fluids
containing glucose, amino acids, multivitamins, and appropriate elec-
trolytes intravenously; they were not fed, and did not receive lipids.
To study the endogenous surfactant PC palmitate production, all
newborn baboons received a constant intravenous infusion of the sta-
ble isotope [U-
 
13
 
C]glucose for 24 h, starting immediately after birth
(t 
 
5
 
 0), at a rate of 0.17 mg/kg/min. Arterial blood (0.5 ml) was drawn
at 0, 12, 18, and 24 h, for determination of plasma glucose enrichment.
Tracheal aspirates were obtained every 12 h during the study period
of 6 d. After instillation of 0.5 ml of saline into the endotracheal tube,
aspiration was performed with a 5F catheter, and the aspirate was
frozen.
At 144 h (6 d), the animals were killed with pentobarbital. Alveo-
lar wash was performed 
 
in situ
 
 by filling the lungs with 0.9% NaCl at
4
 
8 
 
C and recovering the fluid by syringe (2). The lavage procedure was
repeated five times. The lungs were removed, weighed, and homoge-
nized and aliquots were frozen.
 
Analytical Procedures
 
The tracheal aspirates, alveolar washes, lung homogenates, and plasma
glucose samples were processed as described previously (5). In brief,
blood was collected and directly centrifuged to separate plasma and
cells. Plasma was delipidated with chloroform and methanol (13). The
water fraction was passed over anion- and cation-exchange resin. The
eluate containing the glucose was derivatized to an aldonitril pentace-
tate derivative (14). After thawing, the tracheal aspirate and alveolar
wash were vortexed and centrifuged at 450 
 
3
 
 
 
g
 
 for 10 min at 4
 
8 
 
C, and
the pellet was discarded. From the tracheal aspirate, alveolar wash,
and lung homogenate, lipids were extracted (15). PC was isolated
from the lipid extract by thin-layer chromatography (16). The PC was
transmethylated to form fatty acid methyl esters (17). The saturated
(Sat) PC pool size was measured in the alveolar wash and lung homo-
genate by treatment of the lipid fractions with osmium tetroxide (18).
Saturated PC was isolated by column chromatography using alumina,
and quantified by phosphorus assay (19).
 
Determination of 
 
13
 
C Enrichment
 
The 
 
13
 
C enrichment of plasma glucose and of palmitate in surfactant
PC was measured by gas chromatography–combustion interface–iso-
tope ratio mass spectrometry (GC–CI–IRMS) (VG Isotech, Mid-
dlewich, Cheshire, UK) as previously described (5). For glucose, 1 
 
m
 
l
was injected onto a 25 m 
 
3
 
 0.25 mm, 0.11 
 
m
 
m HT-5 capillary column
(Scientific Glass Engineering, Victoria, Australia), with a split ratio of
30:1. The oven temperature was isothermal at 220
 
8
 
 C. For PC palmi-
tate analysis, 1 
 
m
 
l was injected on a 30-m Omega wax column (Su-
pelco, Zwijndrecht, The Netherlands). The injection and oven tem-
perature were 45
 
8 
 
C for 2 min and raised at 15
 
8
 
 C/min to 175
 
8
 
 C, held
for 15 min at 175
 
8
 
 C, and subsequently increased by 2
 
8
 
 C/min to 240
 
8
 
 C.
The enrichment was expressed in atom percent excess (APE), which
represents the increase in the percentage of 
 
13
 
C atoms in total carbon
dioxide from the combusted compounds above baseline enrichment
(before isotope infusion). Enrichments were corrected for the contri-
bution of unlabeled carbon atoms added during derivatization. Calcu-
lations were performed as described previously (5) for palmitic acid
 
only, as this is by far the most abundant fatty acid in PC. Tissue-bound
and alveolar surfactant were regarded as one pool because studies in
newborn rabbits showed that recycling is 
 
z 
 
16 times faster than the 
 
de
novo
 
 synthesis and clearance (20). The first appearance of enrichment
was defined as the time delay between the start of the [U-
 
13
 
C]glucose
infusion and the detection of enriched palmitic acid in surfactant PC.
The first appearance of enrichment was calculated by plotting the re-
gression line for the linear increase of the enrichment-versus-time
curve, and extrapolating it to baseline enrichment. The fractional syn-
thesis rate (FSR) of palmitic acid was expressed as the percentage of
the total surfactant PC palmitate pool synthesized from glucose per
day. It was calculated by dividing the slope of the linear increase in en-
richment of PC palmitate by the steady state enrichment of plasma
glucose (5, 21). The absolute synthesis rate (ASR) of surfactant PC
from glucose only, was calculated by multiplying the FSR by the total
lung Sat PC pool size. The value for the total lung Sat PC pool was the
Sat PC pool size measured at birth in seven similar baboons (
 
z 
 
38
 
m
 
mol of Sat PC per kilogram) plus the amount of Sat PC in the exoge-
nous surfactant given to the animals at birth (
 
z 
 
68 
 
m
 
mol of Sat PC per
kilogram) (2).
 
Data Analysis
 
Data are presented as means 
 
6
 
 standard error. The nonparametric
Mann–Whitney U test was applied to compare groups. A value of p 
 
,
 
0.05 was accepted as significant.
 
RESULTS
 
The six control baboons and the four baboons exposed prena-
tally to betamethasone (beta group) had similar birth weights:
394 
 
6
 
 65 and 340 
 
6
 
 27 g, respectively. The two groups had
similar P
 
O2
 
 and P
 
CO2
 
 values while on similar ventilatory set-
tings as reported previously (2).
The 
 
13
 
C enrichment of plasma glucose reached similar
steady states in all baboons during the period of isotope infu-
sion (3.29 
 
6
 
 0.38 in controls and 3.29 
 
6
 
 0.16 APE in the beta
group). The mean curves for 
 
13
 
C enrichment of palmitic acid
in surfactant PC recovered from tracheal aspirates for both
groups are shown in Figure 1. The first appearance of enrich-
ment in surfactant PC was similar at 27.6 
 
6
 
 2.4 h for controls
and 26.0 
 
6
 
 4.5 h for the beta group (Table 1). The 
 
13
 
C enrich-
ment of PC palmitate increased linearly in both groups and
the enrichment was significantly higher in the beta group as
compared with the control group during the interval from
48 to 96 h (p 
 
,
 
 0.05). The FSR was significantly increased in
Figure 1. 13C labeling of palmitic acid of surfactant phosphatidyl-
choline (PC) (expressed in atom percent excess, APE) after a 24-h
[U-13C]glucose infusion. Pregnant baboons received either prena-
tal betamethasone or saline. When error bars are not visible, they
coincide with the markers. The increased synthesis of PC palmitate
after betamethasone is shown by the increased incorporation of
13C during the first days of life (*p , 0.05).
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the beta group (1.5 
 
6
 
 0.2%/d) compared with controls (0.7 
 
6
 
0.1%/d, p 
 
,
 
 0.02, Table 1) as shown by the increased slopes of
the enrichment-versus-time curves of PC palmitate in the beta
group compared with the slopes in the control group (Figure
2). The ASR of Sat PC from glucose was higher in the beta
group (1.6 
 
6
 
 0.3 
 
m
 
mol/kg/d) compared with the control group
(0.7 
 
6
 
 0.1 
 
m
 
mol/kg/d, p 
 
,
 
 0.02). On Day 6, the total lung Sat
PC pool size (alveolar wash plus lung tissue) was similar for
the control and beta groups (Table 1). The time of maximal
enrichment tended to be earlier in the beta group (90 
 
6
 
 8 h)
than in the control group (107 
 
6
 
 3 h, p 
 
5
 
 0.08). The enrich-
ments at 6 d in tracheal aspirates, alveolar washes, and lung
homogenates were similar for the individual animals, and the
mean values for the control and beta groups also were similar
(tracheal aspirates, 0.052 
 
6
 
 0.030; alveolar washes, 0.050 
 
6
 
0.023; and lung homogenates, 0.056 
 
6
 
 0.026 APE). This im-
plies that the enrichment of surfactant PC palmitate measured
from tracheal aspirates is a good reflection of surfactant PC in
the alveoli and tissue and is in agreement with a fast recycling
of surfactant phospholipids (20).
 
DISCUSSION
 
An understanding of surfactant metabolism is necessary to op-
timize treatment of the very premature human infant with sur-
factant deficiency and possibly other diseases with decreased
surfactant function. We infused the stable isotope [U-
 
13
 
C]glu-
cose in very premature baboons for 24 h and measured 
 
13
 
C
incorporation into palmitic acid in PC in the alveolar compart-
ment. The 
 
13
 
C-labeled PC increased slowly, reached the maxi-
mum value more than 4 d after the start of the isotope infusion,
and remained high at Day 6. These data show that the endoge-
nous synthesis and secretion of PC is a slow process and that
endogenously synthesized surfactant remains in the lung for a
long time in the preterm primate. Five days after birth, the ba-
boons also received an intravenous bolus of radioactive palmi-
tate labeled with 
 
3
 
H and the specific activity in surfactant PC
was measured at killing 24 h later, as described (2). The per-
centage of surfactant PC secreted to the alveoli was only 
 
z 
 
7.5%
in 24 h. This slow rate of secretion is compatible with the ki-
netics calculated from the stable isotope data. A slow metabo-
lism of surfactant has been described in nonprimate animals.
In studies of newborn rabbits and lambs, maximal alveolar en-
richments were found 35 to 60 h after a single injection of radio-
labeled palmitic acid (20, 22, 23). In term newborn sheep and
term newborn rabbits, half-lives of [
 
3
 
H]palmitate in surfactant
PC were 
 
z 
 
11.6 and 2–4.5 d, respectively (20, 24, 25).
In comparison with human preterm infants, the first ap-
pearance of enrichment in the alveolar compartment was sig-
nificantly later in the baboons (
 
z 
 
27 versus 
 
z 
 
19 h) (5). The
 
TABLE 1
MEASUREMENT OF
 
13
 
C ENRICHMENT AND KINETICS OF PC PALMITATE IN
BABOONS EXPOSED OR NOT EXPOSED TO PRENATAL BETAMETHASONE
 
First Appearance
of Enrichment
(
 
h
 
)
Maximal
Enrichment
Time
(
 
h
 
)
Fractional
Synthesis
Rate
(
 
%
 
/
 
d
 
)
Absolute
Synthesis
Rate
(
 
m
 
mol/kg/d
 
)
Lung Sat PC
Pool on Day 6
(
 
m
 
mol/kg
 
)
Control group 27.6 
 
6
 
 2.4 107 
 
6
 
 3 0.7 
 
6
 
 0.1 0.7 
 
6
 
 0.1 186 
 
6
 
 32
Beta group 26.0 
 
6
 
 4.5 90 
 
6 
 
8 1.5 
 
6
 
 0.2 1.6
 
 6
 
 0.3 199 
 
6
 
 13
p Value NS 0.08 0.02 0.02 NS
* Ten pregnant baboons were randomized to prenatal betamethasone or saline. After preterm delivery, baboons received [U-
 
13
 
C]glu-
cose for 24 h and 
 
13
 
C enrichment of palmitic acid in surfactant phosphatidylcholine (PC) was measured for 6 d. Kinetic parameters were
calculated using enrichment-versus-time curves from plasma glucose and surfactant PC palmitate, as described in M
 
ETHODS
 
 and R
 
ESULTS
 
. Sat-
urated PC pool size was measured after killing on Day 6. Statistical analysis to compare groups was performed with the Mann–Whitney
U test.
Figure 2. Linear increase in 13C enrichment of palmitic acid in surfactant phosphatidylcholine (PC). Preg-
nant baboons received either prenatal betamethasone (beta) or saline (controls). The regression line for
each preterm baboon is shown. For calculation of the time delay of first appearance of enrichment, the re-
gression line was extrapolated to zero enrichment. The fractional synthesis rate (FSR) was calculated by di-
viding the slope of the regression line by steady state enrichment of plasma glucose. As plasma glucose
enrichment was identical in both groups, the increased FSR is directly represented by the increased slopes
in the betamethasone group compared with the control group.
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time of maximal enrichment in steroid-treated baboons (
 
z 
 
90 h)
was comparable to the time of maximal enrichment in steroid-
treated human preterm infants (
 
z 
 
70 h). In the present study,
the absolute production of Sat PC from glucose in the beta
group of 
 
z 
 
1.6 
 
m
 
mol/kg/d, was lower than 
 
z 
 
4.3 
 
m
 
mol/kg/d in
preterm human infants treated with prenatal corticosteroids
and exogenous surfactant (5). These comparisons suggest a
slower surfactant synthesis from glucose in the preterm ba-
boon as compared with the human preterm infant, but do not
show the contributions of other precursors. These baboons
were more immature than the preterm human infants, which
may explain the lower synthesis rates. The effects of gesta-
tional age or degree of lung immaturity have not been evalu-
ated by these techniques in either preterm humans or baboons.
We also found that prenatal corticosteroids significantly
stimulated the incorporation of palmitate derived from glucose
into PC: the FSR in the beta group was increased by 
 
z 
 
129%
relative to controls and the absolute production rate was in-
creased in the beta group by 
 
z 
 
128% relative to controls (Ta-
ble 1). The PC palmitate tended to be maximally enriched
earlier in the beta group (
 
z 
 
90 h) than in the controls (
 
z 
 
107 h,
p 
 
, 0.08, Table 1, Figure 1), which is also compatible with stim-
ulated 13C incorporation from plasma glucose into PC palmi-
tate by betamethasone.
In vitro studies support the idea that glucocorticoids en-
hance surfactant synthesis (8–10). Glucose incorporation into
surfactant PC in perfused rat lungs is increased by betametha-
sone (26). However, data on pool size measurements as an in-
dication of surfactant synthesis in vivo are conflicting. In some
studies with newborn rabbits, preterm monkeys, and lambs
chronically catheterized in utero, corticosteroid treatment 2–3 d
before delivery increased surfactant PC pool sizes in alveolar
lavage and lung tissue significantly after birth (27–30). In con-
trast, other studies in large animals show no prenatal steroid-
induced increase in the alveolar (9, 31–34) or total lung Sat PC
pool size after birth (9, 31–33). Ballard and coworkers and
Ikegami and colleagues did not find an increase in total lung
Sat PC pool size at birth in preterm lambs when glucocorti-
coids were administered 2 to 4 d before preterm delivery (11,
31). However, when steroids were administered 1 wk before
delivery, the total lung Sat PC pool sizes at birth increased sig-
nificantly (11, 31). In the present study, we did not measure
surfactant PC pool sizes at birth. We demonstrated that the
processes of synthesis and secretion are slow and that the pro-
duction rate of Sat PC from glucose in preterm newborns is
low compared with the total Sat PC pool on Day 6. Therefore,
the pool size will not increase significantly until several days
after exposure to betamethasone. This low synthesis rate rela-
tive to the pool size may explain why most studies find long
delays between prenatal glucocorticoid treatment and in-
creased surfactant PC pools (11, 31).
The dosage and exposure time to steroids, the species (48 h
of exposure in a rat is relatively long compared with lambs or
baboons), and the experimental conditions that could cause
secondary stress to the fetus also may contribute to discrepan-
cies in the various reports of steroids on surfactant metabolism.
In the present study, there was no effect of prenatal be-
tamethasone treatment on Sat PC pool size in total lung at
Day 6 (Table 1). Probably physiological changes after birth
and therapeutic interventions such as ventilation have larger
effects on surfactant metabolism than do prenatal glucocorti-
coids. Such effects are consistent with the findings by Seidner
and coworkers, who showed that the lung tissue Sat PC pool
size was larger in the very preterm baboon after 6 d of ventila-
tion (125 d of gestation plus 6 d of ventilation) than in either
the near term baboon (175 d of gestation) or the adult baboon
(2). A theoretical explanation for the fact that we did not find
increased pool sizes on Day 6 could be that prenatal be-
tamethasone stimulates both synthesis and clearance of sur-
factant as shown by Fiascione and colleagues in preterm rab-
bits (35). However, in the present study the clearance of
exogenous labeled surfactant was not increased (2).
In the type II pneumocyte, glucose is a primary precursor
for fatty acids used for the synthesis of surfactant PC. This is
especially true in a state of relative fatty acid deficiency, as in
the present study (36, 37). The baboons did not receive any
lipids during the entire study period, and the fat stores in these
very premature baboons are minimal. Sanders and coworkers
showed that the conversion of glucose to palmitic acid is a fast
process (38). Other substrates for surfactant PC are present as
well, such as intracellular glycogen, fatty acids, lactate, pyru-
vate, and ketone bodies. The overall kinetics for surfactant PC
presented, and the increased synthesis rates after glucocorti-
coids administration, are measured from glucose only and may
not represent total surfactant synthesis. The synthesis rates
are valid from this precursor but are probably underestima-
tions; a more direct precursor of PC palmitate such as palmitic
acid may yield more accurate estimations of absolute synthesis
rates but ignores the importance of lipogenesis in the type II
cell. It is, in the present study, unclear whether prenatal ste-
roid stimulates the use of other precursors and how they influ-
ence glucose enrichment in the type II cell. In vitro, steroids
increase glycogenolysis in the type II cell, which is associated
with synthesis of surfactant PC; whether this occurs in the liv-
ing primate has not been studied. If prenatal steroids in-
creased glycogenolysis in the type II cell during the period of
labeled glucose incorporation into surfactant PC palmitate,
then the glucose as a precursor would be diluted, resulting in a
lower enrichment of surfactant PC palmitate after steroids.
We found, however, increased 13C enrichment of surfactant
PC palmitate. It is unlikely that glycogen depletion had al-
ready occurred before birth, as in a few baboons no glycogen
depletion was found by electron microscopy after 6 d of venti-
lation (2). Glucose can be used to describe surfactant metabo-
lism, to evaluate differences between groups, and to study ef-
fects of interventions and clinical conditions. In addition,
glucose can be used safely and easily in critically ill preterm
human infants.
In conclusion, the data show that endogenous surfactant
synthesis and turnover are slow processes. The endogenous
synthesis of surfactant PC from glucose is stimulated within
48 h by prenatal betamethasone after delivery of the very pre-
mature baboon.
Acknowledgment : The writers thank Ingrid H. T. Luijendijk, Ad de Bruijn,
and Annemiek de Raadt (Department of Pediatrics, Erasmus University Rot-
terdam) for excellent technical assistance.
References
1. Ikegami, M., A. H. Jobe, T. Yamada, A. Priestly, L. Ruffini, E. Rider,
and S. R. Seidner. 1989. Surfactant metabolism in surfactant-treated
preterm ventilated lambs. J. Appl. Physiol. 67:429–437.
2. Seidner, S. R., A. H. Jobe, J. J. Coalson, and M. Ikegami. 1998. Abnor-
mal surfactant metabolism and function in preterm ventilated ba-
boons. Am. J. Respir. Crit. Care Med. 158:1982–1989.
3. Jackson, J. C., S. Palmer, W. E. Truog, T. A. Standaert, J. H. Murphy,
and W. A. Hodson. 1986. Surfactant quantity and composition during
recovery from hyaline membrane disease. Pediatr. Res. 20:1243–1247.
4. Hallman, M., T. A. Merritt, M. Pohjavuori, and L. Gluck. 1986. Effect of
surfactant substitution on lung effluent phospholipids in respiratory
distress syndrome: evaluation of surfactant phospholipid turnover,
pool size, and the relationship to severity of respiratory failure. Pedi-
atr. Res. 20:1228–1235.
5. Bunt, J. E. H., L. J. I. Zimmermann, J. L. D. Wattimena, R. H. van Beek,
Bunt, Carnielli, Seidner, et al.: Surfactant Metabolism in Preterm Baboons 1485
P. J. J. Sauer, and V. P. Carnielli. 1998. Endogenous surfactant turn-
over in preterm infants measured with stable isotopes. Am. J. Respir.
Crit. Care Med. 157:810–814.
6. Beck, J. C., W. Mitzner, J. W. Johnson, G. M. Hutchins, J. M. Foidart,
W. T. London, A. E. Palmer, and R. Scott. 1981. Betamethasone and
the rhesus fetus: effect on lung morphometry and connective tissue.
Pediatr. Res. 15:235–240.
7. Walther, F. J., M. Ikegami, D. Warburton, and D. H. Polk. 1991. Corti-
costeroids, thyrotropin-releasing hormone, and antioxidant enzymes
in preterm lamb lungs. Pediatr. Res. 30:518–521.
8. Pope, T. S., and S. A. Rooney. 1987. Effects of glucocorticoid and thy-
roid hormones on regulatory enzymes of fatty acid synthesis and gly-
cogen metabolism in developing fetal rat lung. Biochim. Biophys.
Acta 918:141–148.
9. Chen, C. M., M. Ikegami, T. Ueda, D. H. Polk, and A. H. Jobe. 1995. Ex-
ogenous surfactant function in very preterm lambs with and without
fetal corticosteroid treatment. J. Appl. Physiol. 78:955–960.
10. Liley, H. G., R. T. White, R. G. Warr, B. J. Benson, S. Hawgood, and
P. L. Ballard. 1989. Regulation of messenger RNAs for the hydropho-
bic surfactant proteins in human lung. J. Clin. Invest. 83:1191–1197.
11. Ballard, P. L., Y. Ning, D. Polk, M. Ikegami, and A. H. Jobe. 1997. Glu-
cocorticoid regulation of surfactant components in immature lambs.
Am. J. Physiol. 273:L1048–L1057.
12. Ikegami, M., D. Berry, T. Elkady, A. Pettenazzo, S. Seidner, and A.
Jobe. 1987. Corticosteroids and surfactant change lung function and
protein leaks in the lungs of ventilated premature rabbits. J. Clin. In-
vest. 79:1371–1378.
13. Folch, J., M. Lees, and H. S. Stanley. 1957. A simple method for the iso-
lation and purification of total lipids from animal tissues. J. Biol.
Chem. 226:497–509.
14. Pfaffenberger, C. D., J. Szafranek, M. G. Horning, and E. C. Horning.
1975. Gas chromatographic determination of polyols and aldoses in
human urine as polyacetates and aldononitrile polyacetates. Anal. Bio-
chem. 63:501–512.
15. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extrac-
tion and purification. Can. J. Biochem. Physiol. 37:911–917.
16. Touchstone, J. C., J. C. Chen, and K. M. Beaver. 1979. Improved separa-
tion of phospholipids in thin layer chromatography. Lipids 15:61–62.
17. Carnielli, V. P., E. J. Sulkers, C. Moretti, J. L. Wattimena, J. B. van Gou-
doever, H. J. Degenhart, F. Zacchello, and P. J. Sauer. 1994. Conver-
sion of octanoic acid into long-chain saturated fatty acids in premature
infants fed a formula containing medium-chain triglycerides. Metabo-
lism 43:1287–1292.
18. Mason, R. J., J. Nellenbogen, and J. A. Clements. 1976. Isolation of di-
saturated phosphatidylcholine with osmium tetroxide. J. Lipid Res.
17:281–284.
19. Bartlett, G. R. 1959. Phosphorus assay in column chromatography. J.
Biol. Chem. 234:466–468.
20. Jacobs, H., A. H. Jobe, M. Ikegami, and S. Jones. 1982. Surfactant phos-
phatidylcholine source, fluxes, and turnover times in 3-day-old, 10-
day-old, and adult rabbits. J. Biol. Chem. 257:1805–1810.
21. Ballmer, P. E., M. A. McNurlan, E. Milne, S. D. Heys, V. Buchan, A. G.
Calder, and P. J. Garlick. 1990. Measurement of albumin synthesis in
humans: a new approach employing stable isotopes. Am. J. Physiol.
259:E797–E803.
22. Ikegami, M., A. H. Jobe, and P. W. Nathanieltsz. 1981. The labeling of
pulmonary surfactant phosphatidylcholine in newborn and adult sheep.
Exp. Lung Res. 2:197–206.
23. Jobe, A., M. Ikegami, I. Sarton-Miller, and L. Barajas. 1980. Surfactant
metabolism of newborn lamb lungs studied in vivo. J. Appl. Physiol.
49:1091–1098.
24. Glatz, T., M. Ikegami, and A. H. Jobe. 1982. Metabolism of exogenously
administered natural surfactant in the newborn lamb. Pediatr. Res. 16:
711–715.
25. Jobe, A. H., E. Kirkpatrick, and L. Gluck. 1978. Lecithin appearance
and apparent biologic half-life in term newborn rabbit lung. Pediatr.
Res. 12:669–675.
26. Patterson, C. E., K. S. Davis, D. E. Beckman, and R. A. Rhoades. 1986.
Fatty acid synthesis in the fetal lung: relationship to surfactant lipids.
Biochim. Biophys. Acta 878:110–126.
27. Rooney, S. A., L. I. Gobran, P. A. Marino, W. M. Maniscalco, and I.
Gross. 1979. Effects of betamethasone on phospholipid content, com-
position and biosynthesis in the fetal rabbit lung. Biochim. Biophys.
Acta 572:64–76.
28. Kessler, D. L., W. E. Truog, J. H. Murphy, S. Palmer, T. A. Standaert,
D. E. Woodrum, and W. A. Hodson. 1982. Experimental hyaline
membrane disease in the premature monkey: effects of antenatal dex-
amethasone. Am. Rev. Respir. Dis. 126:62–69.
29. Warburton, D., L. Parton, S. Buckley, L. Cosico, G. Enns, and T. Saluna.
1988. Combined effects of corticosteroid, thyroid hormones, and beta-
agonist on surfactant, pulmonary mechanics, and beta-receptor bind-
ing in fetal lamb lung. Pediatr. Res. 24:166–170.
30. Platzker, A. C., J. A. Kitterman, E. J. Mescher, J. A. Clements, and
W. H. Tooley. 1975. Surfactant in the lung and tracheal fluid of the
fetal lamb and acceleration of its appearance by dexamethasone. Pedi-
atrics 56:554–561.
31. Ikegami, M., D. H. Polk, A. H. Jobe, J. Newnham, P. Sly, R. Kohan, and
R. Kelly. 1996. Effect of interval from fetal corticosteroid treatment to
delivery on postnatal lung function of preterm lambs. J. Appl. Physiol.
80:591–597.
32. Ikegami, M., D. H. Polk, A. H. Jobe, J. Newnham, P. Sly, R. Kohen, and
R. Kelly. 1995. Postnatal lung function in lambs after fetal hormone
treatment. Effects of gestational age. Am. J. Respir. Crit. Care Med.
152:1256–1261.
33. Ikegami, M., D. Polk, and A. Jobe. 1996. Minimum interval from fetal
betamethasone treatment to postnatal lung responses in preterm
lambs. Am. J. Obstet. Gynecol. 174:1408–1413.
34. Polk, D. H., M. Ikegami, A. H. Jobe, J. Newnham, P. Sly, R. Kohen, and
R. Kelly. 1995. Postnatal lung function in preterm lambs: effects of a
single exposure to betamethasone and thyroid hormones. Am. J. Ob-
stet. Gynecol. 172:872–881.
35. Fiascone, J. M., M. R. Mercurio, D. M. Lima, and H. C. Jacobs. 1990.
Corticosteroids and intratracheal surfactant both alter the distribution
between the airways and lung tissue of intratracheally administered
radiolabeled phosphatidylcholine in the preterm rabbit. Exp. Lung
Res. 16:311–321.
36. Maniscalco, W. M., J. N. Finkelstein, and A. B. Parkhurst. 1983. De novo
fatty acid synthesis by freshly isolated alveolar type II epithelial cells.
Biochim. Biophys. Acta 751:462–469.
37. Batenburg, J. J., W. J. Longmore, and L. M. van Golde. 1978. The syn-
thesis of phosphatidylcholine by adult rat lung alveolar type II epithe-
lial cells in primary culture. Biochim. Biophys. Acta 529:160–170.
38. Sanders, R. L., M. J. Engle, and W. H. Douglas. 1981. Effect of dexa-
methasone upon surfactant phosphatidylcholine and phosphatidylglyc-
erol synthesis in organotypic cultures of type II cells. Biochim. Bio-
phys. Acta 664:380–388.
